Status:
COMPLETED
The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study
Lead Sponsor:
Queen's University
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Irritable bowel syndrome (IBS) is a chronic gastrointestinal illness of unknown cause whose symptoms include abdominal pain, bloating and altered bowel pattern. Diet has been shown to influence the ba...
Eligibility Criteria
Inclusion
- Meet Rome III criteria for IBS
- Willing to undergo dietary intervention
Exclusion
- History of Gastric, Small Bowel or Colonic Surgery
- History of Inflammatory Bowel Disease
- Celiac Disease
- Unable to come off following medications: antibiotics, laxatives, narcotics, sedatives
- On a pre specified diet
- Pregnant
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01829932
Start Date
April 1 2013
End Date
December 1 2014
Last Update
October 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hotel Dieu Hospital
Kingston, Ontario, Canada, K7L 5G2